SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-240580
Filing Date
2021-08-09
Accepted
2021-08-09 17:00:25
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d243911ds3.htm S-3 375722
2 EX-4.2 d243911dex42.htm EX-4.2 353777
3 EX-5.1 d243911dex51.htm EX-5.1 26049
4 EX-23.1 d243911dex231.htm EX-23.1 1514
5 GRAPHIC g243911g0807171439627.jpg GRAPHIC 3252
6 GRAPHIC g243911g0807171439861.jpg GRAPHIC 1414
7 GRAPHIC g243911g25h31.jpg GRAPHIC 34435
  Complete submission text file 0001193125-21-240580.txt   812442
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258644 | Film No.: 211157296
SIC: 2834 Pharmaceutical Preparations